Abdullah, Wahida B.

HRN: 21-29-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2022
CO-AMOXICLAV 625MG (TAB)
05/06/2022
05/12/2022
PO
625mg
BID
S/P CS
Waiting Final Action 
05/07/2022
CO-AMOXICLAV 625MG (TAB)
05/07/2022
05/12/2022
IV
625
BID
S/PRIMARY LOW TRANSVERSE CAESAREAN SECTION
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: